Exosome-derived circ-001422 promote tumor-associated macrophage M2 polarization to accelerate the progression of glioma

Author:

Shan Lei1ORCID,Cao Wenpeng,Zeng Zhirui,Sun JianFei,Chen Yunhua,Kuang FaGuang,Luo Shipeng,Lan Jinzhi

Affiliation:

1. School of Basic Medical Sciences, Guizhou Medical University

Abstract

Abstract

Cytokines, tumor cells, and tumor-associated macrophages play crucial roles in the composition of glioma tissue. Studies have demonstrated that certain cytokines can induce M2 polarization of tumor-associated macrophages and contribute to the progression of glioma. Nonetheless, the intricate molecular interactions among cytokines, glioma cells, and tumor-associated macrophages remain largely unexplored. To investigate this cross-talk, a combination of RNA-sequencing, chromatin immunoprecipitation, immunoprecipitation, exosome isolation, and biological experiments were employed. Treatment with IL-6 significantly increased circ-001422 expression in glioma cells. A poorer prognosis was associated with elevated levels of circ-001422 in glioma tissues. Circ-001422 was transcribed directly by STAT3 through binding to its promoter. Co-culturing macrophages with glioma cells knockdown of circ-001422 significantly reduced cell proliferation and invasion. Furthermore, glioma cells were found to transfer circ-001422 to macrophages via an exosomal pathway, promoting M2 polarization. Mechanically, circ-001422 interacted with p300, resulting in STAT3 acetylation, thus promoting nuclear localization and transcriptional activity of STAT3/NF-κB and M2 macrophage polarization. In conclusion, glioma cells released exosomes enriched with circ-001422, which in turn induce M2 macrophage polarization by activating the STAT3/NF-κB pathway, thereby enhancing the aggressive characteristics of glioma cells. Targeting circ-001422 may represent a potential therapeutic approach for glioma.

Publisher

Springer Science and Business Media LLC

Reference35 articles.

1. Malignant Glioma;Wang LM;Adv Exp Med Biol,2023

2. The Present and Future of Optic Pathway Glioma Therapy;Dal Bello S;Cells,2023

3. Gene Therapy for High Grade Glioma: The Clinical Experience;Varela ML;Expert Opin Biol Ther,2023

4. Managing the TME to improve the efficacy of cancer therapy;Bilotta MT;Front Immunol,2022

5. Macrophage M1/M2 polarization;Yunna C;Eur J Pharmacol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3